Skip to main content
Back
Watch Compare

Renalytix plc

Data quality: 100%
Also listed as RENXF OTC
RNLXY
OTC Services Health Services
$1.40
▲ $0.02 (1.45%)
Mkt Cap: 305.91 M
Price
$1.40
Mkt Cap
305.91 M
Day Range
$1.35 — $1.35
52-Week Range
$1.31 — $202.50
Volume
2,192
Open $1.35
50D / 200D Avg
$2.69
48.00% below
50D / 200D Avg
$78.13
98.21% below

Quick Summary

Key Takeaways

Negative free cash flow of -24.44 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-32.74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-1191.75%
Op. Margin-1054.93%

Safety

Debt / Equity
N/A
Current Ratio0.24
Interest CoverageN/A

Valuation

PE (TTM)
-10.91
Below sector avg (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -10.9 -1.2
P/B — 1.4
ROE % — -16.0
Net Margin % -1191.8 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -32.74% Revenue Growth (3Y) -12.21%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.35 M Net Income (TTM) -28.03 M
ROE N/A ROA -413.33%
Gross Margin 12.71% Operating Margin -1054.93%
Net Margin -1191.75% Free Cash Flow (TTM) -24.44 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.24
Interest Coverage N/A Asset Turnover 0.35
Working Capital -9.13 M Tangible Book Value -12.19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10.91 Forward P/E N/A
P/B Ratio N/A P/S Ratio 130.07
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.99%
Market Cap 305.91 M Enterprise Value 305.00 M
Per Share
EPS (Diluted TTM) -0.24 Revenue / Share 0.01
FCF / Share -0.11 OCF / Share -0.11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 87.20%
SBC-Adj. FCF -25.99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2.29 M 3.40 M 2.97 M 1.49 M —
Net Income -33.46 M -45.61 M -45.28 M -35.34 M -9.84 M
EPS (Diluted) -0.31 -0.55 -0.67 — —
Gross Profit 156,000.0 720,000.0 874,000.0 633,000.0 —
Operating Income -29.61 M -42.22 M -53.18 M -31.92 M -10.32 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 364,000.0 508,000.0 489,000.0 282,000.0 70,000.0
Interest Expense — — — — —
Income Tax 4,000.0 2,000.0 25,000.0 — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 7.97 M 30.63 M 50.07 M 78.58 M 20.83 M
Total Liabilities 15.83 M 23.66 M 19.46 M 7.12 M 4.97 M
Shareholders' Equity -7.85 M 6.97 M 30.61 M 71.46 M 15.91 M
Total Debt — — — — —
Cash & Equivalents 4.68 M 24.68 M 41.33 M 65.13 M 13.29 M
Current Assets 6.12 M 26.88 M 44.75 M 66.79 M 14.84 M
Current Liabilities 11.50 M 16.14 M 11.78 M 7.06 M 3.29 M